World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
34431
World Ranking
12099
National Ranking
377

Overview

Stefan Michiels is affiliated with the University of Paris-Saclay in France. Their research primarily focuses on fields related to medicine, including biochemistry, genetics, and molecular biology. Within these broader areas, their work concentrates on oncology, pulmonary and respiratory medicine, cancer research, molecular biology, and radiology, nuclear medicine, and imaging.

The main topics covered by Stefan Michiels include:

  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Breast Cancer Treatment Studies
  • Cancer survivorship and care
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced Breast Cancer Therapies

A number of recent publications by Michiels showcase their involvement in cancer-related research, with a particular focus on next-generation sequencing and the clinical utility of tumor-infiltrating lymphocytes in breast cancer. Selected papers include:

  • "Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group," 2020, Annals of Oncology
  • "The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition," 2021, Annals of Oncology
  • "The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group," 2021, npj Breast Cancer
  • "Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group," 2024, Annals of Oncology
  • "The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice," 2020, The Journal of Pathology

Michiels frequently publishes in several scientific venues, including:

  • Annals of Oncology (27 publications)
  • Cancer Research (23 publications)
  • Journal of Clinical Oncology (21 publications)
  • Clinical Cancer Research (10 publications)
  • Revue d Épidémiologie et de Santé Publique (10 publications)

Their collaborative relationships are reflected in frequent co-authorship with other researchers such as Fabrice André, Inês Vaz-Luís, Benjamin Besse, Barbara Pistilli, and Antonio Di Meglio.

Best Publications

  • Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

    S. Loi;S. Loi;S. Michiels;S. Michiels;R. Salgado;N. Sirtaine

  • Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    Sherene Loi;Nicolas Sirtaine;Fanny Piette;Roberto Salgado

  • Prediction of cancer outcome with microarrays: a multiple random validation strategy.

    Stefan Michiels;Serge Koscielny;Catherine Hill

  • CD4+ follicular helper T cell infiltration predicts breast cancer survival

    Chunyan Gu-Trantien;Sherene Loi;Soizic Garaud;Carole Equeter

  • Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

    François-Clément Bidard;François-Clément Bidard;Dieter Peeters;Tanja Fehm;Franco Nolé

  • Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis

    Gastric (Global Advanced);Xavier Paoletti;Koji Oba

  • Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.

    F. Mosele;J. Remon;J. Mateo;C. B. Westphalen

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

    Sherene Loi;Damien Drubay;Sylvia Adams;Giancarlo Pruneri

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: Results of the MOSCATO 01 trial

    Christophe Massard;Stefan Michiels;Charles Ferté;Marie-Cécile Le Deley

  • Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab A Secondary Analysis of the NeoALTTO Trial

    Roberto Salgado;Carsten Denkert;Christine Campbell;Peter Savas

  • False discovery rate, sensitivity and sample size for microarray studies

    Yudi Pawitan;Stefan Michiels;Serge Koscielny;Arief Gusnanto

  • Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

    Véronique Winnepenninckx;Vladimir Lazar;Stefan Michiels;Philippe Dessen

  • Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis.

    Catherine Delbaldo;Stefan Michiels;Nathalie Syz;Jean-Charles Soria

  • Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.

    P Thirion;S Michiels;J P Pignon;M Buyse

  • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

    Maria Vittoria Dieci;Nina Radosevic-Robin;Susan Fineberg;Gert Van den Eynden

  • Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling

    Hatem A. Azim;Stefan Michiels;Philippe L. Bedard;Sandeep K. Singhal

  • Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer

    Marc Buyse;Tomasz Burzykowski;Kevin Carroll;Stefan Michiels

  • Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

    Fabrice Andre;Bastien Job;Philippe Dessen;Philippe Dessen;Attila Tordai

Frequent Co-Authors

Christos Sotiriou
Christos Sotiriou Université Libre de Bruxelles
Fabrice Andre
Fabrice Andre Institut Gustave Roussy
Sherene Loi
Sherene Loi Peter MacCallum Cancer Centre
Roberto Salgado
Roberto Salgado Peter MacCallum Cancer Centre
Suzette Delaloge
Suzette Delaloge Institut Gustave Roussy
Martine Piccart
Martine Piccart Université Libre de Bruxelles
Denis Larsimont
Denis Larsimont Université Libre de Bruxelles
Carsten Denkert
Carsten Denkert Philipp University of Marburg
Marc Buyse
Marc Buyse Hasselt University
Gilles Vassal
Gilles Vassal Institut Gustave Roussy

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are exploring a future in Medicine but want a flexible or alternative path, online nursing degrees can be a practical option. Many schools now offer cheapest fnp programs online that allow students to become Family Nurse Practitioners while balancing work and study. These programs are not only affordable but also open doors to advanced clinical roles.

For those looking to start or advance a career in nursing, consider the wide variety of affordable nursing programs available online. These accredited courses can prepare you for the licensing exams and provide the foundation needed for entry-level positions.

Ambitious nurses seeking leadership, research, or academic careers can pursue an online phd in nursing. This degree is ideal for those aiming for impactful roles in healthcare education or policy-making.

If you are a registered nurse wanting to expand your qualifications, an rn to bsn online program can help you advance professionally. These bridge programs allow RNs to earn their Bachelor of Science in Nursing quickly and cost-effectively.

Best Scientists Citing Stefan Michiels

Trending Scientists